1 completed, 1 terminated. 2 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
| Phase 3 | 1 | Completed 1 |
Follow Intestinal Atresia: new trials by email Literature Review of Intestinal Atresia trials Research Report on Intestinal Atresia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Compassionate Use of Omegaven in Children Omegaven - Total Parenteral Nutrition-induced Cholestasis, Cholestasis | Phase 2 / Phase 3 | Completed | University of Oklahoma | 63 | 2015-06-01 | 2019-11-25 |
| Safety and Dosing Study of Glucagon-like Peptide 2 (GLP-2) in Infants and Children With Intestinal Failure Glucagon-Like Peptide 2, Glucagon like peptide-2 - Intestinal Failure, Short Bowel Syndrome | Phase 1 / Phase 2 | Terminated | Alberta Children's Hospital | 13 | 2012-01-01 | 2014-12-23 |
Gastroschisis (2) · Short Bowel Syndrome (2) · Cholestasis (1) · Enterocolitis, Necrotizing (1) · Infant Nutrition Disorders (1) · Infant, Premature, Diseases (1) · Intestinal Failure (1) · Malnutrition (1)
Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Digestive System Abnormalities (2) · Digestive System Diseases (2) · Gastrointestinal Diseases (2) · Hernia (2) · Hernia, Abdominal (2) · Intestinal Diseases (2) · Malabsorption Syndromes (2) · Musculoskeletal Abnormalities (2) · Musculoskeletal Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Anatomical (2) · Pathological Conditions, Signs and Symptoms (2) · Postoperative Complications (2)
Glucagon-Like Peptide 2 (1) · fish oil triglycerides (1)
Alberta Children's Hospital (1) · University of Oklahoma (1)
Canada (1) · United States (1)